We are very proud to be the first Institute of its kind in Europe, and we look forward to working to deliver better patient outcomes through advances in the diagnosis, management and treatment of cardiovascular disease.
Cardiovascular disease remains the most common cause of premature mortality in the western world and is a growing and substantial problem in emerging and developing nations.
With the beneﬁts of modern cardiac care, many more patients survive, but often live with distressing symptoms or other limitations. Many cardiovascular conditions are long-term illnesses that will affect patients, and their families and carers over many years. Our mission is to improve the lives of the global community of patients living with cardiac disease. Patients and their families will be central to everything we do: not only in our research but with a role in its planning, analysis and development.
We are grateful for the continuing support of our patients and their families in our search for better approaches to prevention, diagnosis and treatment.
The underlying philosophy for the Institute is that it will be ‘academically led’ but ‘clinically driven’. It provides an exciting opportunity to pool the expertise of cardiovascular clinicians from two major centres together with international leaders in the field of cardiovascular medicine, to head up our ambitions.
As a result, we will be able to both further the education and training of the next generation of specialists in cardiovascular medicine by enabling them to undertake ground breaking research and educating each other in best practice. This research will provide us with the benefits of doing things differently and we can use those findings to develop new and improved services.